Li Xin-li, Xu Qiong, Tong Min, Lu Xin-zheng, Zhang Hai-feng, Zhou Yan-li, Cao Ke-jiang, Huang Jun
Department of Cardiology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Chin Med J (Engl). 2007 Aug 20;120(16):1395-9.
There is significant evidence showing that microalbuminuria and arterial compliance are sensitive markers for early cardiovascular diseases. However, whether microalbuminuria is associated with reduced arterial compliance in Chinese metabolic syndrome (MS) patients remains unknown.
According to the definition of MS proposed by ATPIII in 2001, USA, subjects (n = 362) were divided into three groups according to the number of risk factors: group 1 (control), group 2 (medium, < 3 risk factors) and group 3 (MS, = 3 risk factors). Both large artery compliance (C1) and small artery compliance (C2) were measured with the CVProfilor DO-2020 Cardiovascular Profiling System, and microalbuminuria was evaluated with the ratio of albumin to urine creatinine.
(1) As C1 and C2 levels elasticity decreased, albumin creatinine ratio (ACR) and the prevalence of microalbuminuria increased within those groups with MS risk factors. C1 and C2 were negatively correlated with the ranking of MS risk factors, ACR was positively correlated with the ranking of MS risk factors (all P < 0.05). (2) Subjects were also categorized into a microalbuminuria group and a normal group, C1 and C2 in the microalbuminuria group were lower than in the normal group. (3) Multivariate regression analysis showed that increased systolic blood pressure (SBP) and reduced arterial compliance were the main risk factors for microalbuminuria in the MS group.
The risk of developing microalbuminuria was higher in the subjects with multiple metabolic abnormalities. Increased systolic blood pressure and reduced arterial compliance may be the main predictors for microalbuminuria in MS.
有大量证据表明,微量白蛋白尿和动脉顺应性是早期心血管疾病的敏感标志物。然而,在中国代谢综合征(MS)患者中,微量白蛋白尿是否与动脉顺应性降低相关仍不清楚。
根据2001年美国ATPIII提出的MS定义,将受试者(n = 362)按危险因素数量分为三组:第1组(对照组)、第2组(中度,< 3个危险因素)和第3组(MS组,= 3个危险因素)。使用CVProfilor DO - 2020心血管分析系统测量大动脉顺应性(C1)和小动脉顺应性(C2),并通过白蛋白与尿肌酐的比值评估微量白蛋白尿。
(1)随着C1和C2水平弹性降低,MS危险因素组内的白蛋白肌酐比值(ACR)和微量白蛋白尿患病率增加。C1和C2与MS危险因素排名呈负相关,ACR与MS危险因素排名呈正相关(均P < 0.05)。(2)受试者还被分为微量白蛋白尿组和正常组,微量白蛋白尿组的C1和C2低于正常组。(3)多因素回归分析显示,收缩压(SBP)升高和动脉顺应性降低是MS组微量白蛋白尿的主要危险因素。
具有多种代谢异常的受试者发生微量白蛋白尿的风险更高。收缩压升高和动脉顺应性降低可能是MS患者微量白蛋白尿的主要预测因素。